LON:AZN - AstraZeneca Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started GBX 6,129 +33.00 (+0.54 %) (As of 02/22/2019 04:49 AM ET)Previous CloseGBX 6,096Today's RangeGBX 6,081 - GBX 6,13852-Week RangeGBX 4,260 - GBX 5,520Volume187,886 shsAverage Volume2.31 million shsMarket Capitalization£77.66 billionP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartDividendInsider TradesHeadlinesOptions Chain Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings AstraZeneca (LON:AZN) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.22 Wall Street analysts have issued ratings and price targets for AstraZeneca in the last 12 months. Their average twelve-month price target is GBX 6,222.20The high price target for AZN is GBX 8,500 and the low price target for AZN is GBX 4,080. There are currently 2 sell ratings, 7 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyHoldHoldBuyConsensus Rating Score: 2.502.452.432.57Ratings Breakdown: 2 Sell Rating(s)7 Hold Rating(s)13 Buy Rating(s)0 Strong Buy Rating(s)2 Sell Rating(s)8 Hold Rating(s)12 Buy Rating(s)0 Strong Buy Rating(s)2 Sell Rating(s)8 Hold Rating(s)11 Buy Rating(s)0 Strong Buy Rating(s)2 Sell Rating(s)7 Hold Rating(s)13 Buy Rating(s)1 Strong Buy Rating(s)Consensus Price Target: GBX 6,222.20GBX 6,243.45GBX 5,927.44GBX 5,665.33AstraZeneca (LON:AZN) Consensus Price Target History AstraZeneca (LON:AZN) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetDetails2/22/2019Bryan, Garnier & CoDowngradeNeutral2/18/2019Deutsche BankReiterated RatingBuyGBX 6,9002/15/2019Credit Suisse GroupSet Price TargetBuyGBX 6,3502/14/2019JPMorgan Chase & Co.Set Price TargetBuyGBX 7,1002/14/2019Jefferies Financial GroupSet Price TargetNeutralGBX 6,1002/14/2019Goldman Sachs GroupSet Price TargetSellGBX 4,0802/14/2019Liberum CapitalReiterated RatingHold2/14/2019Shore CapitalReiterated RatingBuy2/5/2019BarclaysReiterated RatingOverweight1/16/2019Societe GeneraleBoost Price TargetBuyGBX 8,400 ➝ GBX 8,50012/14/2018Bank of AmericaSet Price TargetBuyGBX 7,20012/14/2018Morgan StanleyBoost Price TargetEqual weightGBX 5,250 ➝ GBX 6,40011/28/2018HSBCSet Price TargetSellGBX 4,86011/22/2018Kepler Capital MarketsReiterated RatingBuyGBX 6,10011/19/2018InvestecDowngradeHoldGBX 5,500 ➝ GBX 6,30011/19/2018UBS GroupReiterated RatingNeutralGBX 5,90011/9/2018CfraSet Price TargetNeutralGBX 6,2009/25/2018CitigroupReiterated RatingBuyGBX 6,2009/11/2018BNP ParibasSet Price TargetBuyGBX 6,5006/8/2018Berenberg BankReiterated RatingBuyGBX 6,2005/21/2018Sanford C. BernsteinUpgradeOutperformGBX 5,673 ➝ GBX 6,02611/10/2017S&P GlobalSet Price TargetNeutralGBX 5,0009/6/2017NatixisUpgradeNeutral ➝ BuyGBX 5,000 ➝ GBX 5,7387/28/2017Beaufort SecuritiesDowngradeSellGBX 3,900(Data available from 2/22/2017 forward) This page was last updated on 2/22/2019 by MarketBeat.com StaffFeatured Article: What is Depreciation?